Daily Sabah logo

Politics
Diplomacy Legislation War On Terror EU Affairs Elections News Analysis
TÜRKİYE
Istanbul Education Investigations Minorities Expat Corner Diaspora
World
Mid-East Europe Americas Asia Pacific Africa Syrian Crisis Islamophobia
Business
Automotive Economy Energy Finance Tourism Tech Defense Transportation News Analysis
Lifestyle
Health Environment Travel Food Fashion Science Religion History Feature Expat Corner
Arts
Cinema Music Events Portrait Reviews Performing Arts
Sports
Football Basketball Motorsports Tennis
Opinion
Columns Op-Ed Reader's Corner Editorial
PHOTO GALLERY
JOBS ABOUT US RSS PRIVACY CONTACT US
© Turkuvaz Haberleşme ve Yayıncılık 2023

Daily Sabah logo

عربي
  • Politics
    • Diplomacy
    • Legislation
    • War On Terror
    • EU Affairs
    • Elections
    • News Analysis
  • TÜRKİYE
    • Istanbul
    • Education
    • Investigations
    • Minorities
    • Expat Corner
    • Diaspora
  • World
    • Mid-East
    • Europe
    • Americas
    • Asia Pacific
    • Africa
    • Syrian Crisis
    • Islamophobia
  • Business
    • Automotive
    • Economy
    • Energy
    • Finance
    • Tourism
    • Tech
    • Defense
    • Transportation
    • News Analysis
  • Lifestyle
    • Health
    • Environment
    • Travel
    • Food
    • Fashion
    • Science
    • Religion
    • History
    • Feature
    • Expat Corner
  • Arts
    • Cinema
    • Music
    • Events
    • Portrait
    • Reviews
    • Performing Arts
  • Sports
    • Football
    • Basketball
    • Motorsports
    • Tennis
  • Gallery
  • Opinion
    • Columns
    • Op-Ed
    • Reader's Corner
    • Editorial
  • TV
  • Life
  • Health
  • Environment
  • Travel
  • Food
  • Fashion
  • Science
  • Religion
  • History
  • Feature
  • Expat Corner

Vaccines makers testing jabs against new COVID-19 variant omicron

by Anadolu Agency

Ankara Nov 28, 2021 - 6:52 pm GMT+3
Nurse Stephen Connolly vaccinates health care worker Giovanni Franco with a Pfizer-BioNtech coronavirus vaccine booster at the University College Dublin (UCD) campus clinic for inoculating frontline workers in Dublin, Ireland, Nov. 28, 2021. (Reuters Photo)
Nurse Stephen Connolly vaccinates health care worker Giovanni Franco with a Pfizer-BioNtech coronavirus vaccine booster at the University College Dublin (UCD) campus clinic for inoculating frontline workers in Dublin, Ireland, Nov. 28, 2021. (Reuters Photo)
by Anadolu Agency Nov 28, 2021 6:52 pm
RECOMMENDED
Small, widened blood vessels on the skin are usually harmless but can be associated with several diseases and require surgical intervention. (Getty Images Photo)

New innovative Turkish method treats spider veins without surgery

health

Vaccine manufacturers are conducting studies and testing their shots against the new coronavirus variant that was termed "of concern" this week.

American biotechnology company Moderna announced on Friday the new variant known as B.1.1.529 includes mutations seen in the delta variant that increase transmissibility, and it has mutations seen in the beta and delta variants that promote immune escape.

"The combination of mutations represents a significant potential risk to accelerate the waning of natural and vaccine-induced immunity," it warned in a statement.

The company said a booster dose of its COVID-19 vaccine is currently the only available strategy for increasing waning immunity, and it is testing its ability to neutralize the omicron variant, for which the results would be available in the coming weeks.

Moderna said it is testing to see if a higher booster dose of its vaccine would provide protection against omicron.

Another U.S. firm Johnson & Johnson said on Friday it is closely monitoring the new COVID-19 strains with variations in the SARS-CoV-2 spike protein, and the new variant originated in southern Africa is one of them.

The firm said it is testing the effectiveness of its COVID-19 vaccine against the new omicron variant.

British-Swedish biotechnology firm AstraZeneca said it has already started studying the new variant by carrying out research in Botswana and Eswatini, where the variant has been identified.

The company said it aims to collect real world data and see how its COVID-19 vaccine and antibody combination therapy react against the new variant.

‘A cause for concern’

BioNTech announced on Friday it needs two weeks to assess if its vaccine would work against the new variant, adding it took steps months ago with its American partner Pfizer to adapt their messenger RNA (mRNA) vaccine within six weeks and ship first batches within 100 days in case of an escape variant.

South Africa has fully vaccinated 35.3% of its adult population, according to its Department of Health.

The World Health Organization (WHO) on Friday called omicron "a cause for concern" and said it has a high number of spike mutations, believed to be at least 32 at the moment.

The new heavily mutated variant could behave differently against vaccines, treatments, and it may have a different character for transmissibility

The new heavily mutated variant, which might be able to evade vaccines, was detected in Botswana on Nov. 11, and later in Hong Kong.

In Europe, Belgium confirmed the first case of the new variant, while the patient was identified as a young woman who traveled to the country from Egypt via Turkey.

Turkey, the U.S. and many European countries on Friday announced air travel restrictions from South Africa and several other countries on the continent.

RECOMMENDED
Small, widened blood vessels on the skin are usually harmless but can be associated with several diseases and require surgical intervention. (Getty Images Photo)

New innovative Turkish method treats spider veins without surgery

health
  • shortlink copied
  • Last Update: Nov 28, 2021 8:57 pm
    RELATED TOPICS
    fight-against-terrorism DEUTSCHE-BANK US-LIBYA-RELATIONS
    KEYWORDS
    coronavirus omicron vaccine pfizer moderna
    The Daily Sabah Newsletter
    Keep up to date with what’s happening in Turkey, it’s region and the world.
    You can unsubscribe at any time. By signing up you are agreeing to our Terms of Use and Privacy Policy. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
    For the European Union, Cyprus is an instrument to hold Türkiye politically hostage. (Erhan Yalvaç Illustration)

    How to create a united state in Cyprus?

    CYPRUS-ISSUE
    Tourists visit the courtyard of the Süleymaniye Mosque on a sunny day in Istanbul, Türkiye, January 2023. (EPA Photo)

    Türkiye raises bets as foreign arrivals near record, tourism revenues boom

    tourism-in-Türkiye

    Türkiye inks $200M deal with S.Korean firm for parts of MBT Altay

    altay-tank

    Hungary slams Sweden's 'stupidity' on NATO row with Türkiye

    türkiye-hungary-relations
    No Image
    Wuhan: Life after COVID-19 in virus epicenter
    PHOTOGALLERY
    • POLITICS
    • Diplomacy
    • Legislation
    • War On Terror
    • EU Affairs
    • News Analysis
    • TÜRKİYE
    • Istanbul
    • Education
    • Investigations
    • Minorities
    • Diaspora
    • World
    • Mid-East
    • Europe
    • Americas
    • Asia Pacific
    • Africa
    • Syrian Crisis
    • İslamophobia
    • Business
    • Automotive
    • Economy
    • Energy
    • Finance
    • Tourism
    • Tech
    • Defense
    • Transportation
    • News Analysis
    • Lifestyle
    • Health
    • Environment
    • Travel
    • Food
    • Fashion
    • Science
    • Religion
    • History
    • Feature
    • Expat Corner
    • Arts
    • Cinema
    • Music
    • Events
    • Portrait
    • Performing Arts
    • Reviews
    • Sports
    • Football
    • Basketball
    • Motorsports
    • Tennis
    • Opinion
    • Columns
    • Op-Ed
    • Reader's Corner
    • Editorial
    • Photo gallery
    • Jobs
    • privacy
    • about us
    • contact us
    • RSS
    © Turkuvaz Haberleşme ve Yayıncılık 2021